Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Dezember 2025 13:07 ET | Quelle: Hagens Berman Sobol Shapiro LLP

MLTX 2-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

Investors who lost money in MLTX after its stock plunged 90% due to allegedly misleading financial statements are urged to contact Hagens Berman.
11. Dezember 2025 12:53 ET | Quelle: Hagens Berman Sobol Shapiro LLP

MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

Investors who lost money in MoonLake after its stock plunged 90% due to allegedly misleading financial statements are urged to contact Hagens Berman.
08. Dezember 2025 10:45 ET | Quelle: Berger Montague

DEADLINE APPROACHING: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025

PHILADELPHIA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or...
08. Dezember 2025 10:15 ET | Quelle: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
05. Dezember 2025 10:30 ET | Quelle: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
03. Dezember 2025 12:15 ET | Quelle: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
01. Dezember 2025 08:45 ET | Quelle: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
24. November 2025 08:41 ET | Quelle: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
17. November 2025 09:00 ET | Quelle: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
14. November 2025 11:17 ET | Quelle: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Baxter International Inc. (NYSE: BAX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information